Determining the combined effect of MitoQ supplementation and endurance training on cognitive and motor functions, changes in oxidative indices and miR-223 and miR-146a gene expression in postmenopausal and non-menopausal women with multiple sclerosis
Phase 3
Recruiting
- Conditions
- Multiple sclerosis.
- Registration Number
- IRCT20221120056558N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Diagnosis of MS by a neurologist
Being in remission (at least 2 months after the last relapse)
EDSS score less than 6
No acute attacks within 30 Last day
Continuing to take MS drugs
Not taking medicine for fatigue
No taking drugs
Exclusion Criteria
People with cardiovascular, liver and kidney diseases
People with diabetes
Having any skeletal-muscular disorders and obvious congenital anomalies
Having obvious visual impairments
Having certain diseases such as cancer
People with mental disabilities
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method